152 related articles for article (PubMed ID: 38822338)
1. Clinical T1/2 renal cell carcinoma: multiparametric dynamic contrast-enhanced MRI features-based model for the prediction of individual adverse pathology.
Wang K; Guo B; Yao Z; Li G
World J Surg Oncol; 2024 Jun; 22(1):145. PubMed ID: 38822338
[TBL] [Abstract][Full Text] [Related]
2. CT features based preoperative predictors of aggressive pathology for clinical T1 solid renal cell carcinoma and the development of nomogram model.
Wang K; Dong L; Li S; Liu Y; Niu Y; Li G
BMC Cancer; 2024 Jan; 24(1):148. PubMed ID: 38291357
[TBL] [Abstract][Full Text] [Related]
3. Tumor margin irregularity degree is an important preoperative predictor of adverse pathology for clinical T1/2 renal cell carcinoma and the construction of predictive model.
Wang K; Wang G; Liu Y; Dong L; Niu Y; Li G
World J Urol; 2024 Jan; 42(1):64. PubMed ID: 38289390
[TBL] [Abstract][Full Text] [Related]
4. Role of MR texture analysis in histological subtyping and grading of renal cell carcinoma: a preliminary study.
Goyal A; Razik A; Kandasamy D; Seth A; Das P; Ganeshan B; Sharma R
Abdom Radiol (NY); 2019 Oct; 44(10):3336-3349. PubMed ID: 31300850
[TBL] [Abstract][Full Text] [Related]
5. Construction of a Model for Predicting the Risk of pT3 Based on Perioperative Characteristics in cT1 Renal Cell Carcinoma: A Retrospective Study at a Single Institution.
Mei J; Yao Y; Wang X; Liu T; Sun L; Zhang G
Clin Genitourin Cancer; 2024 Aug; 22(4):102122. PubMed ID: 38861916
[TBL] [Abstract][Full Text] [Related]
6. Comparison and development of preoperative systemic inflammation markers-based models for the prediction of unfavorable pathology in newly diagnosed clinical T1 renal cell carcinoma.
Liu H; Tang K; Chen Z; Li Z; Meng X; Xia D
Pathol Res Pract; 2021 Sep; 225():153563. PubMed ID: 34371466
[TBL] [Abstract][Full Text] [Related]
7. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
Halefoglu AM; Ozagari AA
Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
9. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
[No Abstract] [Full Text] [Related]
10. Predictive value of renal tumor contour irregularity score in pathological T3a upstaging of clinical T1 renal cell carcinoma: A multi-institutional study.
Xu P; Zhang S; Cao B; Li Y; Huang J; Lin W; Cheng J; Li H; Chen W; Zhu Y; Jiang S; Hu X; Wu J; Wu Z; Zhou J; Guo J; Wang H
Urol Oncol; 2022 May; 40(5):199.e1-199.e8. PubMed ID: 35365414
[TBL] [Abstract][Full Text] [Related]
11. Head-to-head comparisons of enhanced CT, 68Ga-PSMA-11 PET/CT and 18F-FDG PET/CT in identifying adverse pathology of clear-cell renal cell carcinoma: a prospective study.
Chen SH; Lin BH; Chen SM; Qiu QR; Ruan ZT; Chen ZJ; Wei Y; Zheng QS; Xue XY; Miao WB; Xu N
Int Braz J Urol; 2023; 49(6):716-731. PubMed ID: 37624658
[TBL] [Abstract][Full Text] [Related]
12. Clear Cell Papillary Renal Cell Carcinoma: A Recent Entity With Distinct Imaging Patterns.
Tordjman M; Dbjay J; Chamouni A; Morini A; Timsit MO; Mejean A; Vasiliu V; Eiss D; Correas JM; Verkarre V; Helenon O
AJR Am J Roentgenol; 2020 Mar; 214(3):579-587. PubMed ID: 31770020
[No Abstract] [Full Text] [Related]
13. Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma.
Cornelis F; Tricaud E; Lasserre AS; Petitpierre F; Bernhard JC; Le Bras Y; Yacoub M; Bouzgarrou M; Ravaud A; Grenier N
Eur Radiol; 2015 Jan; 25(1):24-31. PubMed ID: 25117747
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of Clear Cell Renal Cell Carcinoma From Other Renal Cortical Tumors by Use of a Quantitative Multiparametric MRI Approach.
Hötker AM; Mazaheri Y; Wibmer A; Karlo CA; Zheng J; Moskowitz CS; Tickoo SK; Russo P; Hricak H; Akin O
AJR Am J Roentgenol; 2017 Mar; 208(3):W85-W91. PubMed ID: 28095036
[TBL] [Abstract][Full Text] [Related]
15. MRI evaluation of small (<4cm) solid renal masses: multivariate modeling improves diagnostic accuracy for angiomyolipoma without visible fat compared to univariate analysis.
Schieda N; Dilauro M; Moosavi B; Hodgdon T; Cron GO; McInnes MD; Flood TA
Eur Radiol; 2016 Jul; 26(7):2242-51. PubMed ID: 26486936
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors and Oncologic Outcomes for Clinical T1 Renal Cell Carcinoma Upstaging to Pathological T3a and The Construction of Predictive Model: A Retrospective Study.
Wang H; Wang K; Liu C; Wang G; Liu Y; Li G
Urol J; 2023 May; 20(3):148-156. PubMed ID: 36382432
[TBL] [Abstract][Full Text] [Related]
17. Can diffusion-weighted magnetic resonance imaging of clear cell renal carcinoma predict low from high nuclear grade tumors.
Parada Villavicencio C; Mc Carthy RJ; Miller FH
Abdom Radiol (NY); 2017 Apr; 42(4):1241-1249. PubMed ID: 27904923
[TBL] [Abstract][Full Text] [Related]
18. Utility of MRI features in differentiation of central renal cell carcinoma and renal pelvic urothelial carcinoma.
Wehrli NE; Kim MJ; Matza BW; Melamed J; Taneja SS; Rosenkrantz AB
AJR Am J Roentgenol; 2013 Dec; 201(6):1260-7. PubMed ID: 24261365
[TBL] [Abstract][Full Text] [Related]
19. Kidney tumor diffusion-weighted magnetic resonance imaging derived ADC histogram parameters combined with patient characteristics and tumor volume to discriminate oncocytoma from renal cell carcinoma.
van Oostenbrugge TJ; Spenkelink IM; Bokacheva L; Rusinek H; van Amerongen MJ; Langenhuijsen JF; Mulders PFA; Fütterer JJ
Eur J Radiol; 2021 Dec; 145():110013. PubMed ID: 34768055
[TBL] [Abstract][Full Text] [Related]
20. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
